Borregaard (BRG)

TekBot · juni 13, 2025, 8:01am

Borregaard ASA: Change in Group Executive Management

Knut-Harald Bakke has been appointed EVP BioSolutions, effective 1 August
2025. He will also join the Group Executive Management on the same date. Bakke
succeeds Tom Erik Foss-Jacobsen, who will assume the role of CEO on 1 August
…

Vis børsmeldingen

(see stock exchange release dated 23 May 2025).

Bakke currently serves as Director of Investor Relations and has previously held
the position of Energy Director at Borregaard. Prior to joining the company in
2019, he held senior leadership roles at Norsk Hydro, where he was responsible
for global energy market operations. He holds an MSc in Industrial Economics and
Technology Management from the Norwegian University of Science and Technology
(NTNU).

Borregaard will initiate a process to appoint a new Director of Investor
Relations. In the interim, CFO Per Bjarne Lyngstad will assume the
responsibility from 1 August.

Contacts:
Dag Arthur Aasbø, SVP Organisation and Public Affairs, +47 918 34 108
Per Bjarne Lyngstad, CFO, +47 952 44 515

This information is subject to the disclosure requirements pursuant to Section
5-12 of the Norwegian Securities Trading Act.

Kilde

TekBot · juni 17, 2025, 12:42pm

Borregaard ASA: Issuance of Commercial Paper

TekBot · juni 18, 2025, 11:53am

Rentefastsettelse

TekBot · juli 9, 2025, 6:14am

Borregaard ASA: Invitation to Q2 2025 announcement

9 July 2025: Borregaard ASA (“Borregaard”, OSE ticker: BRG)

Presentation of Q2 2025 results
…

Vis børsmeldingen

Borregaard will report second quarter 2025 results on Wednesday 16 July 2025 at
07:00 CEST. A stock exchange announcement will be made. A press release, the
quarterly report and a presentation will be made available on
https://www.borregaard.com/investors/.

A presentation of the second quarter 2025 results will also be held at 08:30
CEST and can be followed live on web-TV at
https://www.borregaard.com/investors/. It will be possible to ask questions via
the web.

All presentations will be held in English.

For more information about Borregaard ASA, please visit
https://www.borregaard.com/.

Contact:
Lotte Kvinlaug, Investor Relations Officer, +47 922 86 909

This information is subject to the disclosure requirements pursuant to Section
5-12 of the Norwegian Securities Trading Act.

Kilde

TekBot · juli 16, 2025, 5:00am

Borregaard ASA: EBITDA1 of NOK 522 million in the 2nd quarter

Borregaard’s operating revenues increased to NOK 2,045 million (NOK 1,949
million)(2) in the 2(nd) quarter of 2025. EBITDA(1) reached NOK 522 million (NOK
510 million). The result in BioSolutions and BioMaterials increased while Fine
…

Vis børsmeldingen

Chemicals had a lower result.

Continued growth in sales to agriculture was the main reason for the improved
result in BioSolutions. In BioMaterials, the result increased due to higher
sales prices, improved product mix and increased sales volume, partly offset by
higher wood costs. Lower sales prices for bioethanol were the main reason for
the weaker result in Fine Chemicals. The net currency effects were positive in
all areas.

Profit before tax was NOK 326 million (NOK 322 million). Earnings per share were
NOK 2.56 (NOK 2.45).

We are pleased to report improved results for both BioSolutions and
BioMaterials, driven by continued strong sales to agriculture and price
increases for speciality cellulose, says President and CEO Per A. Sørlie.

Contacts:
Director Investor Relations, Knut-Harald Bakke, +47 905 79 164
SVP Organisation and Public Affairs, Dag Arthur Aasbø, +47 918 34 108

Operating profit before depreciation, amortisation and other income and
expenses

Figures in parentheses are for the corresponding period in the preceding year

This information is considered to be inside information pursuant to the EU
Market Abuse Regulation and is subject to the disclosure requirements pursuant
to Section 5 - 12 of the Norwegian Securities Trading Act.

This stock exchange announcement was published by Lotte Kvinlaug, Investor
Relations Officer at Borregaard ASA, on 16 July 2025 at 07:00 CEST.

Kilde

TekBot · august 1, 2025, 6:00am

Borregaard ASA: New CEO reinforces Borregaard’s commitment to specialisation and value growth

Tom Erik Foss-Jacobsen assumed his position as Borregaard’s new CEO on 1 August
(see notice to Oslo Stock Exchange 23 May 2025).

…

Vis børsmeldingen

“Borregaard is well positioned with six production units, three R&D centres, and
thirteen sales offices in key markets across Europe, the Americas, and Asia. We
will continue to build on this solid foundation and our highly skilled
organisation to advance our strategy of specialisation and value growth.
Borregaard will continue to build on a strong legacy of specialisation and value
growth. With a deep understanding of our organisation, operations, and strategic
priorities, I am confident in our collective ability to continue driving
sustainable growth and delivering long-term value for Borregaard and its
stakeholders,” says CEO Tom Erik Foss-Jacobsen.

Changes in Borregaard’s Group Executive Management:

Knut-Harald Bakke has been appointed Executive Vice President of the
BioSolutions business area. (See notice to Oslo Stock Exchange 13 June 2025).
Bakke previously served as Director of Investor Relations and earlier held the
position of Energy Director at Borregaard.

Kari Strande has been appointed Senior Vice President, Human Resources with
responsibility for people and organisational development. Strande previously
served as Head of the HR Department.

Dag Arthur Aasbø will continue as part of the Group Executive Management as
Senior Vice President, Public Affairs and Sustainability. He will continue in
his role within public affairs and will also assume overall responsibility for
sustainability.

Ole Gunnar Jakobsen will continue as part of the Group Executive Management as
Executive Vice President, Manufacturing and Technology with overall global
responsibility for manufacturing and technology across Borregaard’s production
units. Jakobsen previously served as Plant Director for the biorefinery in
Sarpsborg.

For more information about the Group Executive Management Team effective from 1
August, please see https://www.borregaard.com/company/organisation/the-group-
executive-management.

Contact:
Per Bjarne Lyngstad, CFO, +47 952 44 515

This information is subject to the disclosure requirements pursuant to Section
5-12 of the Norwegian Securities Trading Act.

Kilde

TekBot · august 1, 2025, 6:06am

Borregaard ASA: Reporting of transactions in Borregaard ASA’s shares made by person discharging managerial responsibilities

Borregaard’s Board of Directors has issued 30,000 share options in relation to
the CEO appointment. Reference is made to stock exchange release on 23 May 2025.

…

Vis børsmeldingen

The options will expire after five years (1 August 2030) and may be exercised in
the last two years. The strike price of the options is NOK 219.31, based on the
volume-weighted average share price (VWAP) over the last three trading days in
July 2025 (29, 30 and 31 July), plus a 10% premium. The strike price will be
adjusted for dividends and other equity transactions.

The maximum annual gain is limited to twice the annual base salary for the CEO.
At least 50% of the proceeds after tax must be used to purchase shares in the
company, and the purchased shares will be locked for a period of three years.
The CEO is expected to acquire shares until his shareholdings equal twice the
base salary.

The primary insider granted stock options has the following holdings of options
and shares in Borregaard after the new share options were issued (new options in
parenthesis):

Tom Erik Foss-Jacobsen holds 108,000 options (30,000) and owns 31,274 shares.

Please see the attached notifications for persons discharging managerial
responsibilities in Borregaard in accordance with Regulation EU 596/2014 (MAR)
article 19.

The total number of outstanding share options is now 1,480,000, equivalent to
1.48% of the number of shares (including 272,448 treasury shares) in Borregaard.

Contact:
Chief Financial Officer, Per Bjarne Lyngstad, +47 952 44 515

This information is subject to the disclosure requirements pursuant to Section
3-1 of the Norwegian Securities Trading Act, cf. Regulation (EU) No 596/2014 of
the European Parliament and of the Council of 16 April 2014 on market abuse
(market abuse regulation) Article 19.

Kilde

TekBot · august 25, 2025, 6:59am

Financial calendar

TekBot · september 15, 2025, 3:03pm

Borregaard ASA: Temporary disruption in production of speciality cellulose

Borregaard has experienced an unforeseen outage at a facility at the Sarpsborg
site, which supplies a key chemical used in the production of speciality
cellulose. During the period of the outage, cellulose production was restricted
…

Vis børsmeldingen

to grades outside standard specifications, resulting in delays of shipments of
certain speciality cellulose grades.

Production of other products at the biorefinery - including lignin-based
biopolymers, bio-vanillin, bioethanol, and cellulose fibrils - remained
unaffected.

Borregaard has worked with internal and external experts to resolve the issue
and minimise the impact on customers.

Deliveries of speciality cellulose in the 3(rd) quarter are now expected to
total approximately 30,000 tonnes, compared with the previously forecasted range
of 35,000 to 38,000 tonnes as communicated in the 2(nd) quarter report. The
estimated negative impact on the Group’s EBITDA for the 3(rd) quarter is in the
range of NOK 40-50 million.

Sarpsborg, 15 September 2025

Contact:
Chief Financial Officer, Per Bjarne Lyngstad, +47 952 44 515

This information is considered to be inside information pursuant to the EU
Market Abuse Regulation and is subject to the disclosure requirements pursuant
to Section 5 - 12 of the Norwegian Securities Trading Act.

This stock exchange announcement was published by Lotte Kvinlaug, Investor
Relations Officer at Borregaard ASA, on 15 September 2025 at 17:03 CEST.

Kilde

TekBot · september 18, 2025, 11:36am

Rentefastsettelse

TekBot · september 25, 2025, 10:47am

Borregaard ASA: NOK 15 million grant for Borregaard’s Biomer project

The Norwegian Research Council (NFR) has awarded NOK 15 million to support
Borregaard’s innovation initiative, Biomer. The project aims to develop bio-
based alternatives to polycarboxylates - fossil-based polymers commonly used in
…

Vis børsmeldingen

agriculture, industry, and household products.

Polycarboxylates are known for their persistence in the environment and high
carbon footprint. Through Biomer, Borregaard will develop new ways to turn
Norwegian bioresources into greener polymers designed to replace these fossil-
based materials.

The project will leverage Borregaard’s advanced biorefinery in Sarpsborg and its
expertise in wood chemistry to deliver sustainable solutions with significantly
lower environmental impact.

“The grant from NFR enables us to accelerate innovation and create new high-
value markets for Norwegian bioresources. Biomer will contribute to reducing the
carbon footprint across agriculture, industry, and consumer products”, says Tom
Erik Foss-Jacobsen, CEO of Borregaard.

This four-year project will run from January 2026 to December 2029.

Contact:
Tone Horvei Bredal, Communications Director, +47 924 67 711

Kilde

TekBot · oktober 6, 2025, 3:19pm

Borregaard ASA: Borregaard to participate in a convertible loan to Alginor

Borregaard, together with the shareholders Must Invest and Hatteland Group, will
act as guarantors for a NOK 200 million convertible loan to Alginor.

…

Vis børsmeldingen

The loan may be converted to new shares by the lenders. The subscription price
upon exercise of the conversion right shall be NOK 10 per share, subject to
adjustment for corporate actions such as share splits, reversed splits,
dividends etc.

All shareholders in Alginor will be invited to participate in the convertible
loan. Depending on the shareholder participation, Borregaard’s share of the loan
will range from NOK 83 to 111 million, paid in two equal tranches in October
2025 and in February 2026.

The convertible loan will be supplemented by an additional uncommitted tap
facility of NOK 100 million.

Furthermore, Alginor has received a commitment for a new secured loan facility
totalling NOK 230 million through Haugesund Sparebank.

This combined financing solution is expected to be sufficient to complete and
commission the ongoing investment in a commercial-scale demonstration plant for
alginates.

For more information about Alginor and the convertible loan, please
see https://alginor.no/.

Contact:

Chief Financial Officer, Per Bjarne Lyngstad, +47 952 44 515

This information is subject to the disclosure requirements pursuant to Section
5-12 of the Norwegian Securities Trading Act.

Kilde

TekBot · oktober 10, 2025, 2:26pm

Borregaard ASA: Issuance of Commercial Paper

TekBot · oktober 15, 2025, 5:47am

Borregaard ASA: Invitation to Q3 2025 announcement

15 October 2025: Borregaard ASA (“Borregaard”, OSE ticker: BRG)

Presentation of Q3 2025 results
…

Vis børsmeldingen

Borregaard will report third quarter 2025 results on Wednesday 22 October 2025
at 07:00 CEST. A stock exchange announcement will be made. A press release, the
quarterly report and a presentation will be made available on
https://www.borregaard.com/investors/.

A presentation of the third quarter 2025 results will also be held at 08:30 CEST
at ABG Sundal Collier, Ruseløkkveien 26, 8(th) floor, Oslo. Attendance in person
is possible. The presentation can be followed live on web-TV at
https://www.borregaard.com/investors/. It will be possible to ask questions via
the web.

All presentations will be held in English.

For more information about Borregaard ASA, please visit
https://www.borregaard.com/.

Contact:
Lotte Kvinlaug, Investor Relations Officer, +47 922 86 909

This information is subject to the disclosure requirements pursuant to Section
5 -12 of the Norwegian Securities Trading Act.

Kilde

TekBot · oktober 22, 2025, 5:01am

Borregaard ASA: EBITDA1 of NOK 440 million in the 3rd quarter

Borregaard’s operating revenues were NOK 1,799 million (NOK 1,949 million)(2) in
the 3(rd) quarter of 2025. EBITDA(1) was NOK 440 million (NOK 524 million). The
result in BioSolutions increased while BioMaterials and Fine Chemicals had lower
…

Vis børsmeldingen

results compared with the 3(rd) quarter of 2024.

The reduced EBITDA(1) was due to lower bioethanol prices and the temporary
disruption in cellulose production at the Sarpsborg site. The negative impact
from this disruption amounts to approximately NOK 40 million. The improvement in
the result for BioSolutions was attributable to sustained growth in sales to
agriculture. In BioMaterials, higher sales prices were more than offset by lower
sales volume. Fine chemical intermediates delivered a strong result. Net
currency effects were positive across all areas.

Profit before tax was NOK 247 million (NOK 326 million). Earnings per share were
NOK 1.96 (NOK 2.51).

We are pleased with the strong development in agricultural sales and our ability
to deliver solid results during uncertain global conditions. This demonstrates
the strength and flexibility of Borregaard’s business model, says CEO Tom Erik
Foss-Jacobsen.

Contacts:
CFO Per Bjarne Lyngstad, +47 952 44 515
Director Communications, Tone Horvei Bredal, +47 924 67 711

Operating profit before depreciation, amortisation and other income and
expenses

Figures in parentheses are for the corresponding period in the preceding year

This information is considered to be inside information pursuant to the EU
Market Abuse Regulation and is subject to the disclosure requirements pursuant
to Section 5 - 12 of the Norwegian Securities Trading Act.

This stock exchange announcement was published by Lotte Kvinlaug, Investor
Relations Officer at Borregaard ASA, on 22 October 2025 at 07:00 CEST.

Kilde

TekBot · desember 10, 2025, 2:16pm

Borregaard ASA: Issuance of Commercial Paper

TekBot · desember 18, 2025, 12:46pm